
The U.S. Food and Drug Administration’s vaccine advisory panel voted unanimously on Tuesday to recommend the agency approve the emergency use of Moderna’s COVID-19 vaccine in children aged 6 to 17. Despite the unanimous support, some panel members worried that trials of the vaccine were conducted before the emergence of the Omicron variant. They noted… read on > read on >